Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study.

Authors:
George E Fragoulis Ioannis Grigoropoulos Evgenia Mavrea Aikaterini Arida Vassiliki-Kalliopi Bournia Gerasimos Evangelatos Kalliopi Fragiadaki Anastasios Karamanakos Evrydiki Kravvariti Stylianos Panopoulos Maria Pappa Konstantinos Thomas Maria G Tektonidou Dimitrios Paraskevis Dimitrios Vassilopoulos Petros P Sfikakis

Rheumatol Int 2021 05 4;41(5):895-902. Epub 2021 Mar 4.

Rheumatology Unit, First Department of Propaedeutic Internal Medicine, Joint Rheumatology Program, National and Kapodistrian University of Athens Medical School, Laiko General Hospital, MikrasAsias 75 Street, 11527, Athens, Greece.

To assess non-compliance and potential changes in seasonal flu vaccination coverage before and during the Covid-19 pandemic in patients with autoimmune rheumatic diseases (ARDs). Consecutive patients with ARDs followed-up in 2 tertiary hospitals were telephone-interviewed (December 12-30, 2020) regarding seasonal flu vaccination during the 2019/20 and 2020/21 time periods. Self-reported disease flares that occurred after flu vaccination, as well as reasons for non-vaccination were recorded. One thousand fifteen patients were included. The rate of flu vaccination increased from 76% before to 83% during the COVID-19 pandemic (p = 0.0001). The rate of self-reported disease flares was < 1% among vaccinated patients. Reasons for not vaccination in both periods, respectively, included: 'was not recommended by their rheumatologists' (35.0vs.12.2%, p < 0.0001), 'did not feel that they would have any benefit' (36.9 vs. 32.6%), felt unsafe to do so (27.5 vs. 30.2%), or other reasons (18.9 vs. 23.8%). By multivariate analysis, age [OR = 1.03 (95% CI 1.02-1.04)] vs. [1.04 (95% CI 1.02-1.05)] and treatment with biologics [OR = 1.66 (95% CI 1.22-2.24) vs. [1.68 (95% CI 1.19-2.38)] were independent factors associated with vaccination in both periods. These findings, although are temporally encouraging, emphasize the need for continuous campaigns aiming at increasing patients' and physicians' awareness about the benefits of vaccination.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-021-04817-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931496PMC
May 2021

Publication Analysis

Top Keywords

flu vaccination
16
covid-19 pandemic
12
disease flares
8
seasonal flu
8
rheumatic diseases
8
patients autoimmune
8
self-reported disease
8
autoimmune rheumatic
8
vaccination
5
2020/21 time
4
ards followed-up
4
time periods
4
periods self-reported
4
patients ards
4
2019/20 2020/21
4
vaccination 2019/20
4
telephone-interviewed december
4
december 12-30
4
flares occurred
4
tertiary hospitals
4

Keyword Occurance

Similar Publications

Decomposing Racial and Ethnic Disparities in Nursing Home Influenza Vaccination.

Authors:
Melissa R Riester Elliott Bosco Barbara H Bardenheier Patience Moyo Rosa R Baier Melissa Eliot Joe B Silva Stefan Gravenstein Robertus van Aalst Ayman Chit Matthew M Loiacono Andrew R Zullo

J Am Med Dir Assoc 2021 Apr 7. Epub 2021 Apr 7.

Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, USA; Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, RI, USA; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI, USA.

Objectives: Quantify how observable characteristics contribute to influenza vaccination disparities among White, Black, and Hispanic nursing home (NH) residents.

Design: Retrospective cohort.

Setting And Participants: Short- and long-stay U. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.

Authors:
Mozaffar Aznab Narges Eskandari Roozbahani Homa Moazen

Support Care Cancer 2021 Apr 10. Epub 2021 Apr 10.

Department of Biostatics and Epidemiology, Shahid Sadoughi University of Medical Science, Yazd, Iran.

Background: According to the recommendation of the Centers for Disease Control and Prevention (CDC), getting influenza vaccines during the coronavirus (COVID-19) pandemics is especially important for people with certain underlying medical conditions, like cancer. Due to the similarities between the symptoms of influenza and COVID-19, receiving the flu vaccine in suspicious cases can be helpful because it will make it easier to request a medical test and diagnosis. In this study, the value of influenza vaccination in the cancer population was investigated. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

T cell reactivity to regulatory factor X4 in type 1 narcolepsy.

Authors:
Guo Luo Selina Yogeshwar Ling Lin Emmanuel Jean-Marie Mignot

Sci Rep 2021 Apr 9;11(1):7841. Epub 2021 Apr 9.

Department of Psychiatry and Behavioral Sciences, Stanford University Center for Sleep Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.

Type 1 narcolepsy is strongly (98%) associated with human leukocyte antigen (HLA) class II DQA1*01:02/DQB1*06:02 (DQ0602) and highly associated with T cell receptor (TCR) alpha locus polymorphism as well as other immune regulatory loci. Increased incidence of narcolepsy was detected following the 2009 H1N1 pandemic and linked to Pandemrix vaccination, strongly supporting that narcolepsy is an autoimmune disorder. Although recent results suggest CD4+ T cell reactivity to neuropeptide hypocretin/orexin and cross-reactive flu peptide is involved, identification of other autoantigens has remained elusive. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

One "misunderstood" health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis.

Authors:
Qing Chun Lu Tie Yun Zhang Pravesh Kumar Bundhun Cheng Chen

BMC Public Health 2021 Apr 9;21(1):703. Epub 2021 Apr 9.

Department of Broadcasting and Television, School of Journalism and Information Communication, Huazhong University of Science and Technology, Wuhan, 430000, People's Republic of China.

Background: The American College of Obstetricians and Gynecologists (ACOG) makes certain recommendations including the annual influenza vaccination of pregnant and pre-pregnant women during influenza (flu) season with an inactivated influenza vaccine as soon as it becomes available. The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices in association with ACOG state that the vaccine is safe to be given any trimester during pregnancy. However, due to a lack of communication, the public is unaware of the effects of influenza A vaccination in pregnancy. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study.

Authors:
Uta Kiltz Aylin Celik Styliani Tsiami Bjoern Buehring Xenofon Baraliakos Ioana Andreica David Kiefer Juergen Braun

RMD Open 2021 Apr;7(1)

Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany.

Objective: To evaluate the prevalence of infections, prevalence of hospitalisation due to infections, the vaccination status and perceived screening of infections prior to the start of biologic disease modifying antirheumatic drugs (bDMARDs) of a patient cohort with chronic inflammatory rheumatic diseases (CIRD).

Methods: Consecutive CIRD patients reporting to our specialised centre were prospectively included (n=975) in this cross-sectional study. Data on comorbidities including infections, treatment, vaccination status, screening for latent tuberculosis infection (LTBI) and hepatitis B (HepB) were collected. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap